Showing results (2751-2760 of 3,166) with videos related to
Sort By:
Pageof 317
Neuro-Oncology|August 27, 2011
Stereotactic brachytherapy of low-grade cerebral glioma after tumor resectionBogdana Suchorska, Maximilian Ruge, Harald Treuer, et al.Neuro-Oncology|May 12, 2011
Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytomaDerek R Johnson, David W Kimmel, Patrick A Burch, et al.Neuro-Oncology|June 4, 2011
Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivoArti B Gaur, Susan L Holbeck, Nancy H Colburn, et al.Neuro-Oncology|June 4, 2011
Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastomaBaisakhi Raychaudhuri, Patricia Rayman, Joanna Ireland, et al.Neuro-Oncology|June 4, 2011
High β-catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expressionJunxia Zhang, Kai Huang, Zhendong Shi, et al.Neuro-Oncology|June 4, 2011
Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapiesDemirkan B Gürsel, Yvette S Connell-Albert, Robert G Tuskan, et al.Neuro-Oncology|June 14, 2011
Hypofractionated stereotactic radiotherapy with CyberKnife for nonfunctioning pituitary adenoma: high local control with low toxicityHiromitsu Iwata, Kengo Sato, Koshi Tatewaki, et al.Neuro-Oncology|February 1, 2012
A phase I study of LY317615 (enzastaurin) and temozolomide in patients with gliomas (EORTC trial 26054)Roy Rampling, Marc Sanson, Thiery Gorlia, et al.Neuro-Oncology|October 21, 2011
Cognitive functions in primary CNS lymphoma after single or combined modality regimensDenise D Correa, Weiji Shi, Lauren E Abrey, et al.Neuro-Oncology|October 22, 2011
Role of diffusion tensor magnetic resonance tractography in predicting the extent of resection in glioma surgeryAntonella Castellano, Lorenzo Bello, Caterina Michelozzi, et al.Pageof 317